BBHC
EBS icon

Brown Brothers Harriman & Co’s Emergent Biosolutions EBS Stock Holding History

Brown Brothers Harriman & Co’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-289
Closed -$6K – 1321
2022
Q3 		$6K Buy
+289
New +$8.04K ﹤0.01% 1258

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brown Brothers Harriman & Co's EBS Position: Q4 2022 in Review

Brown Brothers Harriman & Co sold out of Emergent Biosolutions (EBS) in Q4 2022, closing a stake of 289 shares — an estimated $6K sold.

Brown Brothers Harriman & Co first reported a position in EBS in Q3 2022 and held it in 1 quarter. The position peaked at $6K in Q3 2022. 198 funds tracked by Wall St. Rank hold EBS as of Q4 2022.

  • Brown Brothers Harriman & Co reported no remaining Emergent Biosolutions position as of Q4 2022 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 289 Emergent Biosolutions shares in Q4 2022, an estimated $6K.
  • Brown Brothers Harriman & Co first reported a position in Emergent Biosolutions in Q3 2022 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's Emergent Biosolutions position peaked at $6K in Q3 2022.
  • 198 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2022, filed 9 Feb 2023.